TC
The startup develops medical devices for the contaminant-free collection of blood cultures, enabling precise sepsis diagnosis and treatment of sudden cardiac arrest. By minimizing human error in sample collection, the technology enhances patient outcomes in critical care settings.
Updated 3 months ago
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops medical devices for the contaminant-free collection of blood cultures, enabling precise sepsis diagnosis and treatment of sudden cardiac arrest. By minimizing human error in sample collection, the technology enhances patient outcomes in critical care settings.